AI can help cell and gene therapy firms gain deeper insights about their complex production processes. The ultimate benefit of the technology will be helping industry move from reactive to predictive manufacturing. The post AI Could Give CGT Sector Deeper Manufacturing Insights and Greater Control appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.